|
TMOD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.55111512312578E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
4.058100E-03 |
| Normal-vs-Stage3 |
5.056700E-03 |
| Normal-vs-Stage4 |
1.813020E-01 |
| Stage1-vs-Stage2 |
5.788300E-02 |
| Stage1-vs-Stage3 |
1.67760000002737E-06 |
| Stage1-vs-Stage4 |
1.025370E-04 |
| Stage2-vs-Stage3 |
2.272400E-01 |
| Stage2-vs-Stage4 |
1.598550E-01 |
| Stage3-vs-Stage4 |
5.801200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.62012633811537E-14 |
| Normal-vs-AfricanAmerican |
1.178190E-03 |
| Normal-vs-Asian |
1.981170E-01 |
| Caucasian-vs-AfricanAmerican |
3.940600E-01 |
| Caucasian-vs-Asian |
6.145000E-01 |
| AfricanAmerican-vs-Asian |
9.524400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57529989053273E-10 |
| Normal-vs-Female |
7.43110017964455E-11 |
| Male-vs-Female |
2.344000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.288050E-02 |
| Normal-vs-Age(41-60Yrs) |
1.56696877695595E-12 |
| Normal-vs-Age(61-80Yrs) |
1.1922999998415E-07 |
| Normal-vs-Age(81-100Yrs) |
4.416000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.992400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.227200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.617600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.098100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.336890E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.077400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.571900E-04 |
| Normal-vs-Grade 2 |
1.62481139653892E-12 |
| Normal-vs-Grade 3 |
1.791100E-04 |
| Normal-vs-Grade 4 |
2.539800E-01 |
| Grade 1-vs-Grade 2 |
1.792820E-01 |
| Grade 1-vs-Grade 3 |
3.142900E-03 |
| Grade 1-vs-Grade 4 |
4.952900E-04 |
| Grade 2-vs-Grade 3 |
1.06730000393185E-08 |
| Grade 2-vs-Grade 4 |
9.59499999999558E-05 |
| Grade 3-vs-Grade 4 |
5.267200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.10245146345278E-13 |
| Normal-vs-ccB subtype |
1.05610000000755E-06 |
| ccA subtype-vs-ccB subtype |
1.865660E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02280000527466E-08 |
| Normal-vs-N1 |
8.916800E-01 |
| N0-vs-N1 |
9.130200E-02 |
|
|
